Immunological response of protective antibody against serotype O FMDV using biosynthetic peptide vaccine
You YongJin; Xu QuangXing; Zhao HongXing; Wu ZhengFang; Rao Zhong; Zheng ZhaoXin; Guo JieYan; Jin JianPin; Sheng ZuTian; He BingYao; He YongQiang; Du QingYun
Acta Agriculturae Shanghai 13(4): 1-3
1997
Accession: 003166997
Guineapigs and pigs vaccinated with the biosynthetic peptide (20AA-14AA-20AA) vaccine expressed in pXZ500 produced good immunological responses in the form of protective antibodies. Guineapigs inoculated with 16 micro g and pigs with 0.346 mg doses of 20AA-14AA-20AA on days 0 and 21 were fully protected on day 40 against virulent foot and mouth disease virus (FMDV).
PDF emailed within 1 workday: $29.90
Related References
Horsington, J.; Perez, C.B.; Maradei, E.; Novo, S.G.; Gonzales, J.L.; Singanallur, N.B.; Bonastre, P.; Vosloo, W. 2017: Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination Vaccine 35(38): 5179-5185Wang, G.; Pan, L.; Zhang, Y.; Wang, Y.; Zhang, Z.; Lü, J.; Zhou, P.; Fang, Y.; Jiang, S. 2011: Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge Plos one 6(11): E27605
Horsington, J.; Nfon, C.; Bittner, H.; Durr, P.A.; Singanallur, N.; Alexandersen, S.; Vosloo, W. 2018: The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV a strain from South East Asia Plos one 13(6): E0195302
Xu QuanXing; You YongJin; Zhao HongXing; Wu ZhenFang; Rao Zhong; Zhou Zhiai; Sheng ZuTian; He BingYao; He YongQiang; Du QingYun; Zheng ZaoXin; Guo JieYan; Jin JianPin 1998: Immune efficiency of a biosynthetic peptide vaccine against foot and mouth disease virus serotype O Acta Agriculturae Shanghai 14(1): 1-3
Venkataraman, R.; Rai, D.V.; Pattnaik, B.; Mukhopadhyay, A.K. 1994: Protective and antibody response to a synthetic peptide foot-and-mouth disease vaccine in cattle Indian Journal of Animal Sciences 64(1): 9-13
Beignon, A.-S.; Brown, F.; Eftekhari, P.; Kramer, E.; Briand, J.-P.; Muller, S.; Partidos, C.D. 2005: A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses Veterinary Immunology and Immunopathology 104(3-4): 273-280
Wang, D.; Yang, S.; Yin, S.; Shang, Y.; Du, P.; Guo, J.; He, J.; Cai, J.; Liu, X. 2015: Characterization of single-domain antibodies against Foot and Mouth Disease Virus (FMDV) serotype O from a camelid and imaging of FMDV in baby hamster kidney-21 cells with single-domain antibody-quantum dots probes Bmc Veterinary Research 11: 120
Wang, D.M.; Zhu, J.B.; Peng, M.; Zhou, P. 2008: Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive Transgenic Research 17(6): 1163-1170
Yin, C.; Chen, W.; Hu, Q.; Wen, Z.; Wang, X.; Ge, J.; Yin, Q.; Zhi, H.; Xia, C.; Bu, Z. 2014: Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1 Veterinary research 45: 62
Wang, J.-L.; Liu, M.-Q.; Han, J.; Chen, W.-Z.; Cong, W.; Cheng, G.; Gao, Y.-H.; Lu, Y.-G.; Chen, J.-L.; Zuo, X.-P.; Yan, W.-Y.; Zheng, Z.-X. 2007: A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide Veterinary Microbiology 125(3-4): 224-231
Li, Y.; Aggarwal, N.; Takamatsu, H.-H.; Sterling, C.M.A.; Voyce, C.; Barnett, P.V. 2006: Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O Vaccine 24(21): 4602-4606
Borca, M.V.; Moore, D.M.; Srikumaran, S.; Morgan, D.O. 1990: Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12 Viral Immunology 3(2): 147-160
Qadeer, S.; Khan, M.S.; Joyia, F.A.; Zia, M.A. 2021: Immunogenic profiling and designing of a novel vaccine from capsid proteins of FMDV serotype Asia-1 through reverse vaccinology Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 93: 104925
Ma, L.; Liu, Y.-s.; Ding, Y.-z.; Chen, H.-t.; Zhou, J.-h.; Liu, W.-q.; Wang, M.; Zhang, J. 2010: Preparation and characterization of neutralizing monoclonal antibodies against FMDV serotype O with synthetic peptide antigen Hybridoma 29(5): 409-412
Maree, F.F.; Nsamba, P.; Mutowembwa, P.; Rotherham, L.S.; Esterhuysen, J.; Scott, K. 2015: Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge Vaccine 33(25): 2909-2916
Rajasekhar, R.; Hosamani, M.; Basagoudanavar, S.H.; Sreenivasa, B.P.; Tamil Selvan, R.P.; Saravanan, P.; Venkataramanan, R. 2013: Rescue of infective virus from a genome-length cDNA clone of the FMDV serotype O (IND-R2/75) vaccine strain and its characterization Research in Veterinary Science 95(1): 291-297
Hamers, C.; Rehbein, S.; Hudelet, P.; Blanchet, M.; Lapostolle, B.; Cariou, C.; Duboeuf, M.; Goutebroze, S. 2009: Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep Vaccine 27(21): 2789-2793
Prinz, D.M.; Smithson, S.Louise.; Kieber-Emmons, T.; Westerink, M.A.Julie. 2003: Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide Immunology 110(2): 242-249
Wedege, E.; Frøholm, L.O. 1986: Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting Infection and Immunity 51(2): 571-578
Kim, T.; Hong, J.-K.; Oem, J.-K.; Lee, K.-N.; Lee, H.-S.; Kim, Y.J.; Ryoo, S.; Ko, Y.-J.; Park, J.-H.; Choi, J.; Lee, S.H.; Jo, H.J.; Lee, M.-H.; Kim, B.; Kim, J. 2019: Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig Vaccine 37(12): 1702-1709